JUDITH BELETE: Open Payments
NPI 1033819859 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,128 in 40 payments from 11 companies in 2025. Trend: 2023 $826 · 2024 $1,254 · 2025 $1,128
Food & beverage: $1,128
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $488 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $204 |
| Novo Nordisk Inc | 3 | $88 |
| PFIZER INC. | 4 | $78 |
| Amgen Inc. | 2 | $54 |
| Daiichi Sankyo Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $44 |
| Exact Sciences Corporation | 2 | $43 |
| ABBVIE INC. | 2 | $39 |
| Hologic Sales and Service, LLC | 1 | $25 |
Products named: FARXIGA, Kerendia, BREZTRI, AIRSUPRA, NURTEC ODT, Ozempic, INJECTAFER, The Cologuard Plus Collection Kit.
Industry payments across NV — which companies pay providers there.
